379
Views
21
CrossRef citations to date
0
Altmetric
Original Articles: Research

Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia

, , , , , & show all
Pages 1207-1218 | Received 10 Apr 2016, Accepted 05 Sep 2016, Published online: 13 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Fieke W. Hoff, Terzah M. Horton & Steven M. Kornblau. (2021) Reverse phase protein arrays in acute leukemia: investigative and methodological challenges. Expert Review of Proteomics 18:12, pages 1087-1097.
Read now
Yu-Jie Wu, Li-xia Li, Lu Liu, Si-shu Zhao, Hai-rong Qiu & Hui Wang. (2020) ASH2L-Promoted HOXC8 Gene Expression Plays a Role in Mixed Lineage Leukemia-Rearranged Acute Leukemia. OncoTargets and Therapy 13, pages 381-387.
Read now
Anneke D. van Dijk, Eveline S. J. M. de Bont & Steven M. Kornblau. (2020) Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective. Expert Review of Proteomics 17:1, pages 1-10.
Read now
Fieke W. Hoff, Chenyue W. Hu, Amina A. Qutub, Eveline S. J. M. de Bont, Terzah M. Horton & Steven M. Kornblau. (2018) Shining a light on cell signaling in leukemia through proteomics: relevance for the clinic. Expert Review of Proteomics 15:7, pages 613-622.
Read now

Articles from other publishers (17)

Ezgi Ozyerli-Goknar, Ezgi Yagmur Kala, Ali Cenk Aksu, Ipek Bulut, Ahmet Cingöz, Sheikh Nizamuddin, Martin Biniossek, Fidan Seker-Polat, Tunc Morova, Can Aztekin, Sonia H. Y. Kung, Hamzah Syed, Nurcan Tuncbag, Mehmet Gönen, Martin Philpott, Adam P. Cribbs, Ceyda Acilan, Nathan A. Lack, Tamer T. Onder, H. T. Marc Timmers & Tugba Bagci-Onder. (2023) Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival. Cell Communication and Signaling 21:1.
Crossref
Muthu Vijai Bharat Vairamani, Harini Hariharan & Satish Ramalingam. 2023. Cancer Genes. Cancer Genes 243 286 .
Zhiqin Yang, Yue Jia, Shaojia Wang, Yongjun Zhang, Wen Fan, Xin Wang, Liang He, Xiaoyu Shen, Xiangqun Yang, Yi Zhang & Hongying Yang. (2023) Retinoblastoma-Binding Protein 5 Regulates H3K4 Methylation Modification to Inhibit the Proliferation of Melanoma Cells by Inactivating the Wnt/β-Catenin and Epithelial-Mesenchymal Transition Pathways. Journal of Oncology 2023, pages 1-19.
Crossref
Ankita Punetha & Deepak Kotiya. (2023) Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice. Proteomes 11:1, pages 2.
Crossref
Wei Zhou, Shilin Xu, Tingfen Deng, Ruiqing Zhou & Caixia Wang. (2021) LncRNA USP30-AS1 promotes the survival of acute myeloid leukemia cells by cis-regulating USP30 and ANKRD13A. Human Cell 35:1, pages 360-378.
Crossref
Young-Tae Lee, Alex Ayoub, Sang-Ho Park, Liang Sha, Jing Xu, Fengbiao Mao, Wei Zheng, Yang Zhang, Uhn-Soo Cho & Yali Dou. (2021) Mechanism for DPY30 and ASH2L intrinsically disordered regions to modulate the MLL/SET1 activity on chromatin. Nature Communications 12:1.
Crossref
Elzbieta Poreba, Krzysztof Lesniewicz & Julia Durzynska. (2020) Aberrant Activity of Histone–Lysine N-Methyltransferase 2 (KMT2) Complexes in Oncogenesis. International Journal of Molecular Sciences 21:24, pages 9340.
Crossref
Gaojianyong Wang & Dimitris Anastassiou. (2020) Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis. Scientific Reports 10:1.
Crossref
Hao Jiang. (2020) The complex activities of the SET1/MLL complex core subunits in development and disease. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1863:7, pages 194560.
Crossref
Joan Serrano-Quílez, Sergi Roig-Soucase & Susana Rodríguez-Navarro. (2020) Sharing Marks: H3K4 Methylation and H2B Ubiquitination as Features of Meiotic Recombination and Transcription. International Journal of Molecular Sciences 21:12, pages 4510.
Crossref
Luciana Rocha-Viegas, Micaela Silbermins, María Florencia Ogara, Joaquín Miguel Pellegrini, Sol Yanel Nuñez, Verónica Edith García, Guillermo Pablo Vicent & Adali Pecci. (2020) Glucocorticoids uncover a critical role for ASH2L on BCL-X expression regulation in leukemia cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1863:1, pages 194475.
Crossref
Sang Ho Park, Alex Ayoub, Young-Tae Lee, Jing Xu, Hanseong Kim, Wei Zheng, Biao Zhang, Liang Sha, Sojin An, Yang Zhang, Michael A. Cianfrocco, Min Su, Yali Dou & Uhn-Soo Cho. (2019) Cryo-EM structure of the human MLL1 core complex bound to the nucleosome. Nature Communications 10:1.
Crossref
Peng Li, Maozu Guo & Bo Sun. (2020) Integration of multi-omics data to mine cancer-related gene modules. Journal of Bioinformatics and Computational Biology 17:06, pages 1950038.
Crossref
Juliane Lüscher-Firzlaff, Nicolas Chatain, Chao-Chung Kuo, Till Braunschweig, Agnieszka Bochyńska, Andrea Ullius, Bernd Denecke, Ivan G. Costa, Steffen Koschmieder & Bernhard Lüscher. (2019) Hematopoietic stem and progenitor cell proliferation and differentiation requires the trithorax protein Ash2l. Scientific Reports 9:1.
Crossref
Lu Wang & Ali Shilatifard. (2019) UTX Mutations in Human Cancer. Cancer Cell 35:2, pages 168-176.
Crossref
Zhenhua Yang, Kushani Shah, Theodore Busby, Keith Giles, Alireza Khodadadi-Jamayran, Wei Li & Hao Jiang. (2018) Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer. Journal of Clinical Investigation 128:8, pages 3605-3618.
Crossref
Agnieszka Bochyńska, Juliane Lüscher-Firzlaff & Bernhard Lüscher. (2018) Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin. Cells 7:3, pages 17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.